| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Kevin J. Hammons
Also a director
Chief Executive Officer
|
60 | Not stated | Not stated | $4,772,869 | |
|
Jason K. Johnson
Executive Vice President and Chief Financial Officer
|
51 | Not stated | 2012 | $1,406,434 | |
|
Justin D. Pitt
President and Chief Legal and Administrative Officer and Assistant Secretary
|
51 | Not stated | 2009 | Not reported | |
|
Phillip A. Posey
Senior Vice President & Chief Accounting Officer
|
41 | Not stated | 2020 | Not reported | |
|
David V. Rice
EVP-Clinical Operations & CMO
Title from the Form 4 dated Jun 1, 2026
|
Not stated | Not stated | Not stated | Not reported | |
|
Kevin A. Stockton
Executive Vice President of Operations and Development
|
55 |
Since 2023
3 years
|
2011 | $2,793,696 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
The proxy filed Apr 2, 2026 describes a review policy but reports no transactions.
Read the policy in the proxyLoading...
